Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baminercept alfa in rheumatoid arthritis (RESPOND-EXT)
NCT00664573Phase 2Terminated
- Sponsor
- Biogen
- Start
- Nov 2007
- Primary completion
- Oct 2008
- Countries
- 8
01
Overview
A Phase 2 trial of baminercept in rheumatoid arthritis (RA), sponsored by Biogen. Started Nov 2007; status: terminated.
02
Drugs
baminercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00664573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664573.